A site where you can find recommended contractors for non-clinical testing|effical " Non-Clinical CROs and Agencies " AnaPath Research

AnaPath Research

Table of Contents
Table of Contents

AnaPath Research is a global CRO based near Barcelona, providing research and development services for various industries including pharmaceuticals, biotechnology, agriculture, and chemistry. This article investigates and summarizes the company's features and information on its disease models.

Non-clinical studies undertaken by AnaPath Research

Conduct a comprehensive safety evaluation

At AnaPath Research, to confirm the safety of new drug candidates,Supports a wide range of in vivo (in the body) testsWe can handle general repeated-dose toxicity studies, reproductive and developmental toxicity studies, and safety pharmacology studies evaluating the central nervous system and cardiovascular system.A specialized team with extensive experience conducts comprehensive risk assessments from the initial stage.We support the development of pharmaceuticals by doing this.

Analysis for biopharmaceuticals

In addition to low-molecular-weight compounds, recombinant proteins, monoclonal antibodies, gene therapy drugs, and otherProvision of analytical services for biologics (biopharmaceuticals)We are engaged in a wide range of specialized bioanalytical services to meet regulatory requirements. This includes method development and validation for pharmacokinetics (PK) and toxicokinetics (TK), as well as measurement of anti-drug antibodies (ADAs) and quantification of biomarkers.

Quality standards based on GLP compliance and AAALAC accreditation

The company is the standard for conducting drug safety tests.GLP (Good Laboratory Practice) certified facilityand we provide reliable test data. Furthermore,Accreditation from AAALAC, an international animal welfare organizationWe also have strict auditing systems in place, implemented by a quality assurance team with many years of experience, ensuring ethical and appropriate handling.

An example of a pathology model held by AnaPath Research

We select and utilize diverse animal models.

AnaPath Research is a CRO that conducts studies directly at its own facilities. For safety assessments and toxicity testing, we appropriately select and utilize a diverse range of animal models, from rodents (rats and mice) to non-rodents (dogs, minipigs, and non-human primates), depending on the characteristics of each compound.

AnaPath Research Non-clinical Study Case

With a track record of safety evaluation testing for various compounds.

While AnaPath Research's official website does not feature specific non-clinical study examples, the company conducts safety evaluation studies for a wide range of compounds.

Due to confidentiality of individual sponsor names and specific development compounds in safety assessment studies, detailed study examples are not disclosed. However, from the era of its predecessor testing facility, the company has decades of experience in conducting GLP-compliant studies across a wide range of fields, including pharmaceuticals, medical devices, and agricultural chemicals, and has a proven track record of contributing to regulatory applications in various countries.

AnaPath Research Company Information

Address Barcelona, Spain
Tel +34 93 719 03 61
Website https://www.anapathresearch.com/
3 Recommended Contract Research Organizations for Non-Clinical Studies
— by Target goal and Expertise

In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D. In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening. Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.

Pharmacology (Efficacy) Studies
Replicate unknown pathological models and
Discovery to clinically oriented drug evaluation
SMC Laboratories, Inc.
SMC Laboratories, Inc.
Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/jp/)
  • SMC Laboratories, Inc. has established a disease models using patented mouse technologies. The company has established proprietary pathological models—particularly in liver disease and fibrosis—and continues to expand their approach across a wide range of models in cancer, inflammation, and metabolic diseases.
  • From exploratory research to clinically oriented efficacy evaluation, SMC offers customized study designs, dosing strategies, and evaluation analysis tailored to each project. Their collaborative approachallows researchers to discuss and refine study plans together with SMC’s expert scientists.

  • With flexible small-scale study options and strong technical support, SMC Laboratories, Inc. is an ideal partner for start-ups, biotech ventures, and academic institutions alike.
Safety Studies
Comprehensive Safety Evaluation for FIH Applications
Labcorp Holdings Inc.
(Labcorp Drug Development)
Labcorp Holdings Inc.
Reference: Labcorp Holdings Inc. official website (https://jp.labcorp.com/)
  • Labcorp Holdings Inc. provides a fully integrated GLP testing system aligned with international regulatory standards, including FDA, EMA, and PMDA requirements. All studies are conducted under ICH-compliant quality assurance, making it ready for data submission.
  • The company has extensive expertise in long-term toxicity studies such as Segment I–III reproductive and carcinogenicity studies, as well as 2-year chronic toxicity assessments.
  • Labcorp Holdings Inc.’s comprehensive approach enables sponsors to efficiently outsource the entire preclinical package from toxicology, toxicokinetic (TK), and safety pharmacology study design to execution. This accelerates a path to First-in-Human (FIH) trials. For most of the global drug developers, this all-in-one service structure minimizes cost, risk, and expedite the time before advancing to clinical phase.
Pharmacokinetic (PK/PD) Studies
High-Precision Bioanalysis for Clinically Predictive PK/PD Evaluation
PhoenixBio Co., Ltd.
PhoenixBio Co., Ltd.
Source: PhoenixBio Co., Ltd. Official Website (https://phoenixbio.co.jp/)
  • PhoenixBio Co., Ltd.offers pharmacokinetic and hepatic metabolism studies using their proprietary PXB-mouse®, a humanized-liver chimeric mouse model. This platform enables the acquisition of data with high clinical correlation in ADME, drug–to-drug interaction studies, bridging the gap between preclinical and clinical stages.
  • With advanced LC-MS/MS-based bioanalysis, PhoenixBio Co., Ltd. provides aseamless workflow from plasma concentration measurement and metabolite identification to quantitative validation.

  • The company offersan integrated evaluation analysiscovering pharmacokinetics, hepatotoxicity, and safety with flexibility to accommodate complex modalities such as oligonucleotide and middle-molecule therapeutics. For compounds where hepatic metabolism is a development bottleneck—or where quantitative, reproducible exposure data are critical—PhoenixBio Co., Ltd. delivers unmatched analytical precision and consistency.

By region
list of animal models
Expertise & Track Record
3 Recommended Contract Non-Clinical Testing Services